Expanding Immunoscore® clinical utility on 3000+ stage III colon cancer patients
03 déc. 2020 07h45 HE
|
HalioDx
Expanding Immunoscore® clinical utility on 3000+ stage III colon cancer patients Marseille, France, December 03, 2020 HalioDx SAS, the immuno-oncology diagnostic company pioneering the immunological...